Search results
FDA to vaccinemakers: Updated COVID shots should target KP.2 variant
Becker’s Hospital Review· 12 hours agoThe FDA is now advising manufacturers to develop the 2024-2025 COVID-19 vaccines using the KP.2 strain for the formula, the agency announced June 13. The update comes just ...
COVID could damage your vision, new study says. Keep an eye out for these symptoms
Fortune· 3 days agoSARS-CoV-2 does so by breaching the blood-retinal barrier, layers of cells that shield the retina, the part of your eye that senses light ...
New Definition Of Long Covid Recommended By Expert Panel
Forbes· 3 days agoIn their report, the group defined LC as, “an infection-associated chronic condition that occurs...
Searle Scholar Award Powers Investigation of Viral | Newswise
Newswise· 4 days agoBetween the ongoing COVID-19 pandemic and the looming concern of avian flu, the question is an...
National Academies Issue New Broad Definition of Long COVID
Medscape· 4 days agoAccording to the 2024 NASEM definition of long COVID issued on June 11, 2024, "Long COVID is an...
US government to fund up to $500 mln for studies on oral, nasal COVID vaccines
Reuters· 21 hours agoThe U.S. Department of Health and Human Services (HHS) said on Thursday it will provide up to $500...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 4 days ago“These findings are consistent across all tested influenza strains (H1N1, H3N2 and B/Victoria) and...
FDA Roundup: June 7, 2024
Morning Times· 7 days agoThis action is based on the totality of the evidence and input from Wednesday's Vaccines and Related Biological Products Advisory Committee, which unanimously voted to recommend...
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 2 days agoRevive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and ...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 1 day ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...